2BBBullish & Bearish
Health Care

Immunome, Inc. (IMNM) Stock Score & Signals

Immunome, Inc. (IMNM) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 50 out of 100.

2BB score and signals

Immunome, Inc.’s current 2BB score is 50 out of 100, built from the signal categories below.

SignalScoreReading
Activity72High
Momentum51Stable
Financial strength36Weak
Quality100Very Strong
Risk41Moderate

Company facts

HeadquartersBothell, Washington, United States
Founded2006
Employees206
52-week range$8.66 – $28.04

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2026-11-04-0.6251$204,000.00
2026-08-19-0.5326$185,456.00
2026-05-12-0.48-0.5736$0.00$226,664.00
2026-03-03-0.76-0.614$0.00$306,000.00